CD14 and chronic myelomonocytic leukemia: To further validate these results, we measured the expression of hsa-miR-150 and hsa-miR-451 in sorted peripheral blood CD14+ of an independent cohort of 139 CMML patients at diagnosis (Supplementary Table 1), using CD14+ sorted from 24 healthy donor blood samples as controls.